Literature DB >> 1313849

Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence.

E Acquas1, G Di Chiara.   

Abstract

To investigate the role of mesolimbic dopamine (DA) in the mechanism of drug dependence, extracellular DA was monitored by transcerebral dialysis in the caudal nucleus accumbens under basal conditions and after challenge with morphine (5 mg/kg s.c.) in control rats and in rats made dependent on and then deprived of morphine. Withdrawal from morphine resulted in a marked reduction of extracellular DA concentrations from control values at 1, 2, 3, and 5 days of withdrawal. After 7 days of withdrawal, DA output was less, but still significantly, reduced. Challenge with morphine resulted in stimulation of DA output in controls (maximum, 35%), no effect on the first day of withdrawal, and stimulation similar to controls' on days 2 and 7 of withdrawal. On day 5 and, particularly, on day 3 of withdrawal, morphine-induced stimulation of DA output was markedly potentiated (maximum, 100 and 160%, respectively). Changes in the sensitivity of DA transmission to morphine challenge were associated with changes in the behavioral stimulant effects of morphine, with tolerance on day 1 and marked sensitization on days 3 and 5 but also on day 7, when morphine-induced stimulation of transmission was no longer potentiated. The results indicate that repeated morphine administration induces a state of dependence in DA neurons and a short-lasting tolerance followed by an increased sensitivity to its stimulant effects on DA transmission. These changes might play an important role in the development of opiate addiction and in the maintenance of opiate self-administration in dependent subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313849     DOI: 10.1111/j.1471-4159.1992.tb10033.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  45 in total

Review 1.  Vaccines against nicotine: how effective are they likely to be in preventing smoking?

Authors:  F J Vocci; C N Chiang
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

3.  Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.

Authors:  Yoichi Kawasaki; Chunyu Jin; Katsuya Suemaru; Hiromu Kawasaki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita; Hiroaki Araki
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study.

Authors:  Sanjay Kasture; Stefania Vinci; Federico Ibba; Alessandro Puddu; Mara Marongiu; Balasubramanian Murali; Augusta Pisanu; Daniele Lecca; Gerald Zernig; Elio Acquas
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

5.  Decreased brain reward produced by ethanol withdrawal.

Authors:  G Schulteis; A Markou; M Cole; G F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

6.  Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence.

Authors:  V Bassareo; G Tanda; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

7.  Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine.

Authors:  J Airio; M Attila; T Leikola-Pelho; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

8.  Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.

Authors:  R A Wise; E Munn
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 9.  The kappa-opiate receptor impacts the pathophysiology and behavior of substance use.

Authors:  David Mysels; Maria A Sullivan
Journal:  Am J Addict       Date:  2009 Jul-Aug

10.  Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal.

Authors:  S Ghosh; K Grasing
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.